Valproic acid is known to alter the expression of SMARCA4 and SMARCD1 in neuroblastoma cells (Hu et al., 2020), and SMARCA genes are suggested as members of the neurogenic transcriptional network control (Higgins et al., 2019). The gene discussed is SMARCD1; the disease is neuroblastoma.